Page last updated: 2024-08-21

adamantane and Scleroderma, Systemic

adamantane has been researched along with Scleroderma, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Fujii, Y; Fukahori, H; Imamura, E; Kitanaga, Y; Kubo, S; Nakahara, Y; Nakayamada, S; Tanaka, Y	1

Other Studies

1 other study(ies) available for adamantane and Scleroderma, Systemic

Article	Year
In vitro pharmacological effects of peficitinib on lymphocyte activation: a potential treatment for systemic sclerosis with JAK inhibitors. Rheumatology (Oxford, England), 2020, 08-01, Volume: 59, Issue:8 Topics: Adamantane; Arthritis, Rheumatoid; Female; Humans; Janus Kinase Inhibitors; Lymphocyte Activation; Lymphocytes; Male; Niacinamide; Phosphorylation; Scleroderma, Systemic; STAT Transcription Factors	2020

Article

Year

In vitro pharmacological effects of peficitinib on lymphocyte activation: a potential treatment for systemic sclerosis with JAK inhibitors.

Rheumatology (Oxford, England), 2020, 08-01, Volume: 59, Issue:8

Topics: Adamantane; Arthritis, Rheumatoid; Female; Humans; Janus Kinase Inhibitors; Lymphocyte Activation; Lymphocytes; Male; Niacinamide; Phosphorylation; Scleroderma, Systemic; STAT Transcription Factors

2020